日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma.

贝伐珠单抗治疗卵巢癌或胶质母细胞瘤患者后的活性定量分析

Lallemand Christophe, Ferrando-Miguel Rosa, Auer Michael, Iglseder Sarah, Czech Theresa, Gaber-Wagener Anouk, Di Pauli Franziska, Deisenhammer Florian, Tovey Michael G

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies

一种用于定量分析治疗性抗体ADCC活性的新型系统

Lallemand, Christophe; Liang, Feifei; Staub, Flore; Simansour, Maud; Vallette, Benoit; Huang, Lue; Ferrando-Miguel, Rosa; Tovey, Michael G

Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC

从血液样本中提取的DNA产量的分析前变异来源:EPIC数据库中50,000个DNA样本的分析

Caboux, Elodie; Lallemand, Christophe; Ferro, Gilles; Hémon, Bertrand; Mendy, Maimuna; Biessy, Carine; Sims, Matt; Wareham, Nick; Britten, Abigail; Boland, Anne; Hutchinson, Amy; Siddiq, Afshan; Vineis, Paolo; Riboli, Elio; Romieu, Isabelle; Rinaldi, Sabina; Gunter, Marc J; Peeters, Petra H M; van der Schouw, Yvonne T; Travis, Ruth; Bueno-de-Mesquita, H Bas; Canzian, Federico; Sánchez, Maria-José; Skeie, Guri; Olsen, Karina Standahl; Lund, Eiliv; Bilbao, Roberto; Sala, Núria; Barricarte, Aurelio; Palli, Domenico; Navarro, Carmen; Panico, Salvatore; Redondo, Maria Luisa; Polidoro, Silvia; Dossus, Laure; Boutron-Ruault, Marie Christine; Clavel-Chapelon, Françoise; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Lagiou, Pagona; Boeing, Heiner; Fisher, Eva; Tumino, Rosario; Agnoli, Claudia; Hainaut, Pierre

Immunogenicity and other problems associated with the use of biopharmaceuticals

生物制药的免疫原性及其他相关问题

Tovey, Michael G; Lallemand, Christophe

GAAP-1: a transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity

GAAP-1:p53 和 IRF-1 的转录激活因子,具有促凋亡活性

Lallemand, Christophe; Palmieri, Marta; Blanchard, Brigitte; Meritet, Jean-Francois; Tovey, Michael G